United States · FDA National Drug Code directory
FILKRI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69448-009_6dd7213f-3c00-4539-9c76-96c904676827
- Product NDC
- 69448-009
- Form
- INJECTION, SOLUTION
- Composition / generic term
- filgrastim-laha
- Labeler
- Accord BioPharma Inc.,
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260715
- Source listing expiry
- 20271231
Source-listed ingredients
- FILGRASTIM — 480 ug/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 BOX (69448-009-03) / .8 mL in 1 SYRINGE · 69448-009-03
- 1 SYRINGE in 1 BOX (69448-009-63) / .8 mL in 1 SYRINGE · 69448-009-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →